67 related articles for article (PubMed ID: 5114365)
1. The effect of intense treatment with hypotensive drugs on structural design of the resistance vessels in spontaneously hypertensive rats.
Folkow B; Hallbäck M; Lundgren Y; Weiss L
Acta Physiol Scand; 1971 Oct; 83(2):280-2. PubMed ID: 5114365
[No Abstract] [Full Text] [Related]
2. Long-term treatment with antihypertensive drugs in spontaneously hypertensive rats (SHR). Effects on blood pressure, survival rate and cardiovascular design.
Weiss L
Acta Physiol Scand; 1974 Jul; 91(3):393-408. PubMed ID: 4844597
[No Abstract] [Full Text] [Related]
3. Aspects of the relation between functional and structural cardiovascular factors in primary hypertension. Experimental studies in spontaneously hypertensive rats.
Weiss L
Acta Physiol Scand Suppl; 1974; 409():1-58. PubMed ID: 4281992
[No Abstract] [Full Text] [Related]
4. Effects of enalapril and hydralazine treatment and withdrawal upon cardiovascular hypertrophy in stroke-prone spontaneously hypertensive rats.
King RA; Smith RM; Krishnan R; Cleary EG
J Hypertens; 1992 Sep; 10(9):919-28. PubMed ID: 1328373
[TBL] [Abstract][Full Text] [Related]
5. Studies on the effect of chronic oral administration of minoxidil and hydralazine on vascular function in spontaneously hypertensive rats.
Greeberg S
J Pharmacol Exp Ther; 1980 Nov; 215(2):279-86. PubMed ID: 7441494
[TBL] [Abstract][Full Text] [Related]
6. Influence of an adrenergic beta-receptor blocking agent on the effect of various hypotensive agents in the hypertensive rat.
Brunner H; Hedwall PR; Meier M
Experientia; 1965 Apr; 21(4):231-2. PubMed ID: 4378905
[No Abstract] [Full Text] [Related]
7. The clinical pharmacology of commonly used antihypertensive drugs.
Melmon KL
Cardiovasc Clin; 1974; 6(2):175-97. PubMed ID: 4155350
[No Abstract] [Full Text] [Related]
8. The effect of prostaglandin E2 on the arterial blood pressure of normotensive and spontaneously hypertensive rats.
Simpson LL
Br J Pharmacol; 1974 Aug; 51(4):559-64. PubMed ID: 4451765
[TBL] [Abstract][Full Text] [Related]
9. Contribution of the central nervous system to the action of several antihypertensive agents (methyldopa, hydralazine and guanethidine).
Baum T; Shropshire AT; Varner LL
J Pharmacol Exp Ther; 1972 Jul; 182(1):135-44. PubMed ID: 5041650
[No Abstract] [Full Text] [Related]
10. Comparative effects of hydralazine and captopril on the cardiovascular changes in spontaneously hypertensive rats.
Limas C; Westrum B; Limas CJ
Am J Pathol; 1984 Dec; 117(3):360-71. PubMed ID: 6391187
[TBL] [Abstract][Full Text] [Related]
11. Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure.
Christensen KL; Jespersen LT; Mulvany MJ
J Hypertens; 1989 Feb; 7(2):83-90. PubMed ID: 2522478
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a novel antihypertensive agent, LY127210, in anesthetized and conscious spontaneously hypertensive rats.
Ruffolo RR; Kurz K; Paget CJ
J Pharmacol Exp Ther; 1985 Jan; 232(1):134-8. PubMed ID: 3838104
[TBL] [Abstract][Full Text] [Related]
13. Preferential renal vasodilator effects of CGP 22979A in conscious spontaneously hypertensive rats.
Smits JF; Struyker-Boudier HA
J Pharmacol Exp Ther; 1985 Mar; 232(3):845-9. PubMed ID: 3973832
[TBL] [Abstract][Full Text] [Related]
14. Effects of long-term antihypertensive treatment on brain metabolism after bilateral carotid artery occlusion in spontaneously hypertensive rats.
Tamaki K; Fujishima M; Nakatomi Y; Ishitsuka T; Ogata J; Omae T
J Neurol Neurosurg Psychiatry; 1979 Dec; 42(12):1141-5. PubMed ID: 533853
[TBL] [Abstract][Full Text] [Related]
15. 2,6-Dichlorobenzylidene amino guanidine acetate (Wy-8678). A new hypotensive agent.
Baum T; Eckfeld DK; Metz N; Dinish JL; Rowles G; Van Pelt R; Shropshire AT; Fernandez SP; Gluckman MI; Bruce WF
Experientia; 1969 Oct; 25(10):1066-7. PubMed ID: 5357105
[No Abstract] [Full Text] [Related]
16. Effect of guanethidine on collagen biosynthesis in blood vessels of hypertensive rats.
Iwatsuki K; Cardinale GJ; Spector S; Udenfriend S
Arch Int Pharmacodyn Ther; 1979 Aug; 240(2):278-84. PubMed ID: 228620
[TBL] [Abstract][Full Text] [Related]
17. Differential influence of the calcium antagonist nitrendipine and the vasodilator hydralazine on normal and elevated blood pressure.
Knorr A; Garthoff B
Arch Int Pharmacodyn Ther; 1984 Jun; 269(2):316-22. PubMed ID: 6476986
[TBL] [Abstract][Full Text] [Related]
18. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Jackson EK; Dubinion JH; Mi Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
[TBL] [Abstract][Full Text] [Related]
19. Hypotensive and diuretic actions of diltiazem in spontaneously hypertensive and Wistar Kyoto rats.
Narita H; Nagao T; Yabana H; Yamaguchi I
J Pharmacol Exp Ther; 1983 Nov; 227(2):472-7. PubMed ID: 6631726
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive activity of cadralazine in experimental hypertensive rats.
Takeyama K; Ikeno A; Minato H; Fukuya F; Nishimura S; Hosoki K; Kadokawa T
Arch Int Pharmacodyn Ther; 1988; 291():163-74. PubMed ID: 3365060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
